The pre and post assessment of glycemic control and patients’ medication adherence of Type 2 diabetes mellitus (T2DM) in pharmacist-managed DMTAC program at Putrajaya Health Clinic / Hajar Mat Noji
According to WHO 2014 data, 9% of adults 18 years and older had diabetes. In 2012 diabetes was the direct cause of 1.5 million deaths. Until this date, diabetes mellitus has become a major healthcare burden in almost all countries in the world. According to the Third National Health and Morbidity...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://ir.uitm.edu.my/id/eprint/25932/1/TM_HAJAR%20MAT%20NOJI%20PH%2017_5.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | According to WHO 2014 data, 9% of adults 18 years and older had
diabetes. In 2012 diabetes was the direct cause of 1.5 million deaths. Until this
date, diabetes mellitus has become a major healthcare burden in almost all
countries in the world. According to the Third National Health and Morbidity
Survey (2006) done by the Ministry of Health Malaysia, the prevalence of
diabetes among Malaysian adults of over 30 years has almost increased by two
folds. WHO states that non-adherence to medications is a major problem whereby
poor adherence can lead to negative health outcomes such as worsened disease or
even mortality. The aim of this study was to evaluate the effectiveness of
pharmacist-managed DMTAC program in improving patients’ glycemic control,
lipid profile, and medication adherence pre and at least 3 months post DMTAC
program. This retrospective cross sectional study was carried out within 3 months
at the out-patient pharmacy of Putrajaya Health Clinic Presint 9. Primary outcome
measure was the glycemic control changes pre and post DMTAC service. Other
relevant clinical parameters changes were the secondary outcome measures. There
was a significant difference of mean HbA1c by -0.82%, which decreased from
10.46% (S = 1.68) to 9.64% (SD = 2.34) (p<0.001). Meanwhile, the reduction of
2.9 mmol/L (p<0.001) in mean FBG was also significant. This statistical
significant difference of HbA1c indicates a positive impact of DMTAC program. |
|---|